These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11418519)

  • 1. The effect of amiloride on amphotericin B-induced hypokalaemia.
    Bearden DT; Muncey LA
    J Antimicrob Chemother; 2001 Jul; 48(1):109-11. PubMed ID: 11418519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia.
    Wazny LD; Brophy DF
    Ann Pharmacother; 2000 Jan; 34(1):94-7. PubMed ID: 10669191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiloride prevents amphotericin B related hypokalaemia in neutropenic patients.
    Smith SR; Galloway MJ; Reilly JT; Davies JM
    J Clin Pathol; 1988 May; 41(5):494-7. PubMed ID: 3290263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Usefulness of Early Potassium Supplementation for Preventing Severe Hypokalemia Induced by Liposomal Amphotericin B in Hematologic Patients: A Retrospective Study.
    Okada N; Azuma M; Imanishi M; Zamami Y; Kirino Y; Nakamura T; Teraoka K; Abe M; Ishizawa K
    Clin Ther; 2018 Feb; 40(2):252-260. PubMed ID: 29305017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Must we really fear toxicity of conventional amphotericin B in oncological patients?
    Mayer J; Doubek M; Vorlìcek J
    Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria lowers the risk of amphotericin B-associated hypokalaemia.
    Mohan S; Ahmed S; Alimohammadi B; Jaitly M; Cheng JT; Pogue VA
    J Antimicrob Chemother; 2007 Sep; 60(3):690-3. PubMed ID: 17597057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study.
    Ota Y; Obata Y; Takazono T; Tashiro M; Wakamura T; Takahashi A; Shiozawa Y; Miyazaki T; Nishino T; Izumikawa K
    BMC Nephrol; 2021 Jun; 22(1):240. PubMed ID: 34193064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the hypokalaemia index based on area over the serum potassium concentration curve and occurrence of acute kidney injury in patients administered liposomal amphotericin B.
    Ueda T; Nakajima K; Ichiki K; Ishikawa K; Yamada K; Tsuchida T; Otani N; Takubo S; Iijima K; Uchino M; Horio Y; Kuwahara R; Kimura T; Murakami Y; Nozaki Y; Nakama S; Miyazaki Y; Takesue Y
    Mycoses; 2024 Jul; 67(7):e13771. PubMed ID: 39031945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypokalemia induced by amphotericin B].
    Edoute Y; Silbershatz I
    Harefuah; 1999 Nov; 137(10):477-80. PubMed ID: 10959350
    [No Abstract]   [Full Text] [Related]  

  • 10. Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients?
    Ural AU; Avcu F; Cetin T; Beyan C; Kaptan K; Nazaroglu NK; Yalcin A
    Eur J Clin Pharmacol; 2002 Jan; 57(11):771-3. PubMed ID: 11868798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.
    Maronde RF; Barr J; Vlachakis ND; Spencer CA; Chan L
    Clin Pharmacol Ther; 1984 Oct; 36(4):431-5. PubMed ID: 6478730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid intravenous infusion of amphotericin B: a pilot study.
    Cruz JM; Peacock JE; Loomer L; Holder LW; Evans GW; Powell BL; Lyerly ES; Capizzi RL
    Am J Med; 1992 Aug; 93(2):123-30. PubMed ID: 1497007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis.
    Yamazaki H; Kondo T; Aoki K; Yamashita K; Takaori-Kondo A
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):123-131. PubMed ID: 29203252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia.
    Shigemi A; Matsumoto K; Ikawa K; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    Int J Antimicrob Agents; 2011 Nov; 38(5):417-20. PubMed ID: 21885259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiloride in Bartter's syndrome.
    Griffing GT; Komanicky P; Aurecchia SA; Sindler BH; Melby JC
    Clin Pharmacol Ther; 1982 Jun; 31(6):713-8. PubMed ID: 7075119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety of long-term administration of conventional amphotericin B in oncology patients].
    Doubek M; Mayer J; Horký D
    Cas Lek Cesk; 2002 Mar; 141(5):156-9. PubMed ID: 11998223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex.
    Kline S; Larsen TA; Fieber L; Fishbach R; Greenwood M; Harris R; Kline MW; Tennican PO; Janoff EN
    Clin Infect Dis; 1995 Nov; 21(5):1154-8. PubMed ID: 8589135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Hypokalemia as a Side Effect of Liposomal Amphotericin in Pediatric Patients.
    Kobayashi R; Keino D; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
    Pediatr Infect Dis J; 2018 May; 37(5):447-450. PubMed ID: 28945677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.
    Wade RL; Chaudhari P; Natoli JL; Taylor RJ; Nathanson BH; Horn DL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):361-7. PubMed ID: 23774005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the pharmacokinetics of liposomal amphotericin B and analysis of the relationship between pharmacokinetics, efficacy and safety in patients with hematological diseases.
    Matsumoto K; Takagi S; Asano-Mori Y; Yamaguchi K; Yuasa M; Kageyama K; Kaji D; Nishida A; Ishiwata K; Yamamoto H; Araoka H; Miyazaki Y; Uchida N; Taniguchi S; Morita K
    J Infect Chemother; 2024 Jun; 30(6):504-510. PubMed ID: 38097040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.